Table 1 Study population characteristics.

Age (years)

45–79

64 ± 6

40–59(n = 23)

60–69(n = 56)

70–79(n = 18)

PSA (ng/mL)

0.6–63

10.7 ± 8.0

<4(n = 4)

4–10(n = 55)

>10(n = 38)

Lesions per patient

1–5

1.4 ± 0.8

1 lesion(n = 70)

2 lesions(n = 18)

3 lesions(n = 6)

4 lesions(n = 1)

5 lesions(n = 2)

Indication

No Prior Biopsy; Elevated PSA(n = 56)

Negative Prior Biopsy; Rising PSA(n = 37)

Active Surveillance for known Prostate Cancer(n = 42)

Staging for clinically significant Prostate Cancer(n = 1)

Other(n = 1)